Status:
COMPLETED
EMD for Treatment of Proximal Class-II Furcation Involvements
Lead Sponsor:
Universidade Estadual Paulista Júlio de Mesquita Filho
Conditions:
Generalized Aggressive Periodontitis
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The aim of the present study is to evaluate the clinical response of proximal furcations treated with enamel matrix derivative proteins (EMD).
Detailed Description
Proximal class-II furcation represents a challeng to periodontal therapy. Studies show that the ultrasonic non-surgical therapy doesn't work in these defects and the guided tissue regeneration therapy...
Eligibility Criteria
Inclusion
- Diagnosis of generalized aggressive periodontitis (Armitage, 1999; American Academy of Periodontology, 2015);
- Have undergone a first approach for periodontal treatment (full-mouth ultrasonic debridement);
- Presence of one proximal class-II furcation presenting probing depth \> 4 mm and bleeding on probing ;
- Good general health;
- Agree to participate in the study and sign the informed consent form (TCLE) after explaining the risks and benefits;
Exclusion
- Systemic problems (cardiovascular alterations, blood dyscrasias, immunodeficiency - ASA III / IV / V) that contraindicate the periodontal procedure;
- Have used antibiotics and anti-inflammatories in the last six months;
- Smoke ≥ 10 cigarettes/day;
- Pregnant or lactating;
- Chronic use of medications that may alter the response of periodontal tissues;
- Indication of antibiotic prophylaxis for dental procedures;
Key Trial Info
Start Date :
October 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2019
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03320135
Start Date
October 20 2017
End Date
May 20 2019
Last Update
June 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Naira Andere
São José dos Campos, São Paulo, Brazil, 12245010